CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• CD45 is the primary tyrosine phosphatase in hematopoietic cells, regulating signaling pathways through dephosphorylation.
• The extracellular domain of CD45 shows significant variability due to alternative splicing and glycosylation, potentially mediating cell-cell interactions.
• This variability allows for the development of monoclonal antibodies targeting specific CD45 epitopes, useful for distinguishing cell populations.

Purpose of the Study:

• To explore the role of CD45 variability in cell interactions.
• To investigate the utility of anti-CD45 antibodies in immunophenotyping and disease contexts.
• To assess the potential of anti-CD45 reagents in modulating lymphocyte function in vitro and in vivo.

Main Methods:

• Utilizing monoclonal anti-CD45 antibodies reactive with differentially spliced and glycosylated epitopes.
• Employing immunophenotyping techniques for hematopoietic malignancies, immunodeficiencies, and autoimmune diseases.
• Conducting in vitro studies to evaluate the effects of anti-CD45 reagents on T and B cell activation.

Main Results:

• Anti-CD45 antibodies can differentiate cell populations based on maturation and function.
• These antibodies are valuable tools in the immunophenotyping of various hematological conditions.
• In vitro studies demonstrated that different anti-CD45 reagents exert distinct activating or inhibiting effects on lymphocyte activation.

Conclusions:

• CD45's structural variability is crucial for its function and interaction capabilities.
• Anti-CD45 antibodies serve as important diagnostic and potentially therapeutic tools in immunology.
• Targeting CD45 offers a promising strategy for selectively modulating lymphocyte function in immune-mediated diseases.